Skip to main content
SpringerLink
Log in

Denosumab

Multiple vertebral fractures following withdrawal of denosumab: 3 case reports

  • Case report
  • Published:
Reactions Weekly Aims and scope

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Reference

  • Dickens L, et al. Oral vs intravenous bisphosphonates for preventing bone loss after denosumab discontinuation. Journal of Bone and Mineral Research 34 (Suppl. 1): 182-183 (plus poster) abstr. LB SAT-1069, Dec 2019 [abstract]

Download references

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Denosumab. Reactions Weekly 1810, 87 (2020). https://doi.org/10.1007/s40278-020-80107-6

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s40278-020-80107-6

Search

Navigation